GMRS vs. CRL: Which Stock Should Value Investors Buy Now?

Zacks
Öffnen unter Zacks
GMRS vs. CRL: Which Stock Should Value Investors Buy Now?

Investors interested in Medical Services stocks are likely familiar with GMR Solutions Inc. (GMRS) and Charles River Laboratories (CRL). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.

There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.

Right now, GMR Solutions Inc. is sporting a Zacks Rank of #1 (Strong Buy), while Charles River Laboratories has a Zacks Rank of #3 (Hold). Investors should feel comfortable knowing that GMRS likely has seen a stronger improvement to its earnings outlook than CRL has recently. But this is just one factor that value investors are interested in.

Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.

The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors.

GMRS currently has a forward P/E ratio of 6.48, while CRL has a forward P/E of 30.05. We also note that GMRS has a PEG ratio of 0.16. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. CRL currently has a PEG ratio of 3.11.

Another notable valuation metric for GMRS is its P/B ratio of 0.7. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. By comparison, CRL has a P/B of 5.08.

These are just a few of the metrics contributing to GMRS's Value grade of A and CRL's Value grade of C.

GMRS sticks out from CRL in both our Zacks Rank and Style Scores models, so value investors will likely feel that GMRS is the better option right now.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
GMR Solutions Inc. (GMRS): Free Stock Analysis Report
 
Charles River Laboratories International, Inc. (CRL): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research